Klotho Neurosciences' stock value surged by 800% due to positive pre-clinical study results on the Klotho gene's anti-aging potential. However, investing in KLTO involves high risks due to its early-stage development, lack of revenue, and volatile stock performance.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing